CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-19 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −14,038 | $142.95 | $2.0M | 5,426,008 |
| 2023-04-19 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −14,062 | $143.61 | $2.0M | 5,411,946 |
| 2023-04-19 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 787,155 | ||
| 2023-04-13 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-04-13 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −30,456 | $160.63 | $4.9M | 5,421,490 |
| 2023-04-13 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −9,444 | $161.16 | $1.5M | 5,412,046 |
| 2023-04-13 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −100 | $161.98 | $16K | 5,411,946 |
| 2023-04-13 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 827,155 | ||
| 2023-04-12 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-04-12 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −12,634 | $155.67 | $2.0M | 5,439,312 |
| 2023-04-12 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −16,650 | $156.69 | $2.6M | 5,422,662 |
| 2023-04-12 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −8,334 | $157.67 | $1.3M | 5,414,328 |
| 2023-04-12 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −2,382 | $158.56 | $378K | 5,411,946 |
| 2023-04-12 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −40,000 | 867,155 | ||
| 2023-04-06 | Bancel Stephane Chief Executive Officer | Exercise or conversion 10b5-1 | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-04-06 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −2,739 | $154.79 | $424K | 5,449,207 |
| 2023-04-06 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −7,602 | $155.58 | $1.2M | 5,441,605 |
| 2023-04-06 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −1,200 | $157.00 | $188K | 5,440,405 |
| 2023-04-06 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −25,343 | $158.19 | $4.0M | 5,415,062 |
| 2023-04-06 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −3,116 | $158.81 | $495K | 5,411,946 |
Page 50 of 66 · 1,314 trades